Last update 23 Jan 2025

Parke Davis (India) Ltd.

Subsidiary Company|
India
| BOM: 500677

Overview

Tags

Nervous System Diseases
Immune System Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Immune System Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
CACNA2D1 x CACNA2D21

Related

1
Drugs associated with Parke Davis (India) Ltd.
Gabapentin
Target
CACNA2D1 x CACNA2D2
Mechanism
CACNA2D1 blockers [+1]
Active Org.
Pfizer Inc.Pfizer Inc. [+6]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Peripheral neuralgia [+9]
Inactive Indication
Amyotrophic Lateral Sclerosis [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US [+1]
First Approval Date30 Dec 1993
100 Clinical Results associated with Parke Davis (India) Ltd.
Login to view more data
0 Patents (Medical) associated with Parke Davis (India) Ltd.
Login to view more data
1
Literatures (Medical) associated with Parke Davis (India) Ltd.
Indian Drugs & Pharmaceuticals Industry
Optimum utilization of centrifuge and reactor in the chemical and pharmaceutical industries
100 Deals associated with Parke Davis (India) Ltd.
Login to view more data
100 Translational Medicine associated with Parke Davis (India) Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Gabapentin
 ( CACNA2D1 x CACNA2D2 )		Epilepsy
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free